Veeda Acquires a European CRO, Heads

Veeda Acquires a European CRO, Heads

By, Admin 27 March 2024

Veeda Clinical Research acquires European CRO, Heads to expand global reach & capabilities

Overview

Veeda Clinical Research a full-service contract research organization (CRO) has acquired Heads, a privately held European CRO, which specializes in conducting clinical trials in oncology. 

About Heads

  • Established in 2010, Heads has operational presence in 25 multiple strategically important locations across Europe, North America and Asia Pacific region.  
  • Through this acquisition, Veeda enters the league of global CROs with integrated capabilities to extend contract research services from discovery to clinical development extending to post commercial launch.

Acquisition Benefits: for Heads

  • The acquisition provides Heads a strong operational platform and an opportunity to expand its expertise and capabilities to the Indian and South-East Asian markets. 
  • India's diverse demographic profile provides a unique opportunity to conduct clinical trials, especially in therapeutic areas including oncology, diabetes, hypertension, infectious diseases, and special diseases.

Acquisition Benefits: for Veeda

  • With this acquisition, Veeda’s global pharmaceutical and biotech clients can now leverage the unique and unparalleled suite of early to late-phase CRO services across Europe, US, and Asia Pacific. 
  • Veeda’s ever-growing relationship with large biopharma companies and access to KOL’s across multiple countries will accelerate execution of global clinical trials in both the western and eastern populations. 
  • In recent years, Veeda has added expertise in the late stage clinical and global trials for large molecules. 
  • High quality and efficient clinical trial execution remains the top priority for the clients of the combined entity. 

Words from CEO: Veeda Clinical Research

Dr. Mahesh Bhalgat, group- CEO, Veeda Clinical Research, said, “With the growing emphasis on global clinical trials, this acquisition now positions Veeda to offer access to a very diverse population for conducting large scale multi-geography trials efficiently. Both organizations are focused towards driving equitable access to trials and fostering the development of innovative treatments worldwide. The acquisition brings together a unique team of scientists and researchers, having deep therapeutic area expertise in the oncology research. This equips Veeda to build long and enduring site relationships across geographies.
 
"There is a very strong cultural fit between Heads and Veeda," said Dr. George Kouvatseas, partner, Heads. Both companies share a dedication to scientific leadership, expansion of highly specialized services to meet the emerging needs of our clients, an uncompromising focus on quality, and a belief that our strength is in our people and the way in which they work together. 

Responsibilities Post Acquisition

  • During the integration phase, Heads will continue to offer uninterrupted support to client programmes. 
  • The Veeda and Heads organization together are committed to nimble operations through a structured integration process without impact to ongoing client programmes.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!